ProShares UltraShort NASDAQ Biotechnology
8 hedge funds and large institutions have $984K invested in ProShares UltraShort NASDAQ Biotechnology in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Holders
8
Holding in Top 10
–
Calls
$8K
Puts
$10K
Top Sellers
| 1 | -$50.3K | |
| 2 | -$44.9K | |
| 3 | -$21.9K | |
| 4 |
Morgan Stanley
New York
|
-$595 |